Problems of post-marketing surveillance.
作者信息
Castle W M, Nicholls J T, Downie C C
出版信息
Br J Clin Pharmacol. 1983 Dec;16(6):581-5. doi: 10.1111/j.1365-2125.1983.tb02225.x.
Abstract
摘要
相似文献
1
Problems of post-marketing surveillance.上市后监测问题。
Br J Clin Pharmacol. 1983 Dec;16(6):581-5. doi: 10.1111/j.1365-2125.1983.tb02225.x.
2
Monitoring of drugs after marketing.药品上市后监测
J R Coll Gen Pract. 1983 Jul;33(252):438-41.
3
The rationale for a post-marketing surveillance.
Hum Reprod. 1987 Jan;2(1):41-4. doi: 10.1093/oxfordjournals.humrep.a136486.
4
Fatal adverse drug reactions of anticancer drugs detected by all-case post-marketing surveillance in Japan.日本全病例上市后监测发现的抗癌药物致死性不良反应。
Jpn J Clin Oncol. 2015 Jun;45(6):588-94. doi: 10.1093/jjco/hyv030. Epub 2015 Mar 10.
5
Post-marketing surveillance or drug acceptability study?上市后监测还是药物可接受性研究？
Br J Clin Pharmacol. 1987 Sep;24(3):281-2. doi: 10.1111/j.1365-2125.1987.tb03170.x.
6
Survey of the spontaneous adverse drug reaction reporting schemes in fifteen countries.十五个国家自发药品不良反应报告制度调查
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):83S-100S. doi: 10.1111/j.1365-2125.1986.tb02988.x.
7
The future of automated record linkage for postmarketing surveillance: a response to Shapiro.
Clin Pharmacol Ther. 1989 Oct;46(4):387-9. doi: 10.1038/clpt.1989.155.
8
The role of automated record linkage in the postmarketing surveillance of drug safety: a critique.自动记录链接在药品安全性上市后监测中的作用：一项批判性分析。
Clin Pharmacol Ther. 1989 Oct;46(4):371-86. doi: 10.1038/clpt.1989.154.
9
Post-marketing surveillance of new drugs.新药上市后监测
J R Coll Gen Pract. 1987 Aug;37(301):337-8.
10
Post-marketing surveillance in the UK (1984).英国的上市后监测（1984年）。
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):71S-75S. doi: 10.1111/j.1365-2125.1986.tb02986.x.
引用本文的文献
1
Postmarketing surveillance of adverse drug reactions.药品不良反应的上市后监测
Br Med J (Clin Res Ed). 1984 May 12;288(6428):1458-9. doi: 10.1136/bmj.288.6428.1458-b.
本文引用的文献
1
Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton.全科医疗中药物不良反应的上市后监测。II：南安普顿大学的处方事件监测。
Br Med J (Clin Res Ed). 1981 Apr 11;282(6271):1216-7. doi: 10.1136/bmj.282.6271.1216.
2
Can postmarketing surveillance help to effect optimal drug therapy?上市后监测能否有助于实现最佳药物治疗？
JAMA. 1979 Nov 30;242(22):2420-2.
3
The case for recording events in clinical trials.临床试验中记录事件的理由。
Br Med J. 1977 Dec 10;2(6101):1523-4. doi: 10.1136/bmj.2.6101.1523.
Zotero 插件